Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia.
about
Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cooperation of IRAK1/4 inhibit ...... acute lymphoblastic leukemia.
@en
Cooperation of IRAK1/4 inhibit ...... acute lymphoblastic leukemia.
@nl
type
label
Cooperation of IRAK1/4 inhibit ...... acute lymphoblastic leukemia.
@en
Cooperation of IRAK1/4 inhibit ...... acute lymphoblastic leukemia.
@nl
prefLabel
Cooperation of IRAK1/4 inhibit ...... acute lymphoblastic leukemia.
@en
Cooperation of IRAK1/4 inhibit ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1476
Cooperation of IRAK1/4 inhibit ...... acute lymphoblastic leukemia.
@en
P2093
Bingyu Zhang
Runming Jin
Xiaoyan Wu
Yining Qiu
Zhenhua Hu
P2860
P304
P356
10.2147/IJN.S146875
P407
P577
2017-10-31T00:00:00Z